- DVBCWPM1 ;ALB/ESW PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 10 Oct 2000
- ;;2.7;AMIE;**34**;Apr 10, 1995
- ;
- TXT ;
- ;;A. Review of Medical Records:
- ;;
- ;;B. Medical History (Subjective Complaints):
- ;; Comment on:
- ;;
- ;; 1. Activity of pulmonary tuberculosis or other mycobacterial disease.
- ;; 2. Date of inactivity if it is not active.
- ;; 3. Identity of organism (if possible).
- ;;
- ;;C. Physical examination (Objective Findings):
- ;; Address each of the following and fully describe current findings:
- ;;
- ;; 1. Extent of structural damage to lungs.
- ;; 2. If patient was hospitalized for 6 months or more, what is the
- ;; condition at the end of hospitalization?
- ;; 3. If patient was hospitalized for 12 months or more, what is the
- ;; condition at the end of hospitalization?
- ;;
- ;;D. Diagnostic and Clinical Tests:
- ;;Provide:
- ;;
- ;;1. Pulmonary Function Tests, if indicated. If performed, include the results
- ;; in the examination report, The FEV-1,FVC, and FEV-1/FVC should be included.
- ;; Both pre- and post-bronchodilatation pulmonary function test results should
- ;; be reported. If post-bronchodilatation test is not conducted in a particular
- ;; case, please provide an explanation of why not. A DLCO may or may not be
- ;; done routinely as part of pulmonary function testing at a particular
- ;; facility. If there is a disparity between the results of different tests,
- ;; please indicate which tests are more likely to accurately reflect
- ;; the severity of the condition.
- ;;
- ;; DLCO note: If DLCO was not done as a routine part of pulmonary function
- ;; testing, the examiner should use his or her judgment, based on
- ;; the specific condition (.e.g., whether it is obstructive,
- ;; interstitial, etc.) and other available information about the condition,
- ;; as to whether a DLCO test is needed, since it is not useful in all
- ;; situations. If it may provide useful information about the severity
- ;; of the condition, it should be requested and reviewed before
- ;; the examination report is submitted. If the examiner determines that
- ;; the DLCO test is not needed, a statement as to why not (e.g., there are
- ;; decreased lung volumes that would not yield valid test results) should be
- ;; included in the report. Such a statement could avoid a remand from BVA
- ;; when the test is not done. However in the case of a BVA remand in which
- ;; the DLCO is requested, the DLCO MUST be done unless there is a medical
- ;; contraindication.
- ;;
- ;;E. Diagnosis:
- ;;
- ;; 1. In reactivated cases, is this reactivation of the old disease
- ;; or a separate and distinct new infection?
- ;;
- ;;ADDITIONAL NOTE TO THE EXAMINER:
- ;;
- ;;In all claims, if the disease is inactive and if the inactivity was confirmed
- ;;at a non-VA facility, obtain the name and mailing address of the facility
- ;;from the veteran so that the Regional Office may request the report.
- ;;
- ;;
- ;;Signature: Date:
- ;;END
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HDVBCWPM1 3142 printed Feb 18, 2025@23:20 Page 2
- DVBCWPM1 ;ALB/ESW PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 10 Oct 2000
- +1 ;;2.7;AMIE;**34**;Apr 10, 1995
- +2 ;
- TXT ;
- +1 ;;A. Review of Medical Records:
- +2 ;;
- +3 ;;B. Medical History (Subjective Complaints):
- +4 ;; Comment on:
- +5 ;;
- +6 ;; 1. Activity of pulmonary tuberculosis or other mycobacterial disease.
- +7 ;; 2. Date of inactivity if it is not active.
- +8 ;; 3. Identity of organism (if possible).
- +9 ;;
- +10 ;;C. Physical examination (Objective Findings):
- +11 ;; Address each of the following and fully describe current findings:
- +12 ;;
- +13 ;; 1. Extent of structural damage to lungs.
- +14 ;; 2. If patient was hospitalized for 6 months or more, what is the
- +15 ;; condition at the end of hospitalization?
- +16 ;; 3. If patient was hospitalized for 12 months or more, what is the
- +17 ;; condition at the end of hospitalization?
- +18 ;;
- +19 ;;D. Diagnostic and Clinical Tests:
- +20 ;;Provide:
- +21 ;;
- +22 ;;1. Pulmonary Function Tests, if indicated. If performed, include the results
- +23 ;; in the examination report, The FEV-1,FVC, and FEV-1/FVC should be included.
- +24 ;; Both pre- and post-bronchodilatation pulmonary function test results should
- +25 ;; be reported. If post-bronchodilatation test is not conducted in a particular
- +26 ;; case, please provide an explanation of why not. A DLCO may or may not be
- +27 ;; done routinely as part of pulmonary function testing at a particular
- +28 ;; facility. If there is a disparity between the results of different tests,
- +29 ;; please indicate which tests are more likely to accurately reflect
- +30 ;; the severity of the condition.
- +31 ;;
- +32 ;; DLCO note: If DLCO was not done as a routine part of pulmonary function
- +33 ;; testing, the examiner should use his or her judgment, based on
- +34 ;; the specific condition (.e.g., whether it is obstructive,
- +35 ;; interstitial, etc.) and other available information about the condition,
- +36 ;; as to whether a DLCO test is needed, since it is not useful in all
- +37 ;; situations. If it may provide useful information about the severity
- +38 ;; of the condition, it should be requested and reviewed before
- +39 ;; the examination report is submitted. If the examiner determines that
- +40 ;; the DLCO test is not needed, a statement as to why not (e.g., there are
- +41 ;; decreased lung volumes that would not yield valid test results) should be
- +42 ;; included in the report. Such a statement could avoid a remand from BVA
- +43 ;; when the test is not done. However in the case of a BVA remand in which
- +44 ;; the DLCO is requested, the DLCO MUST be done unless there is a medical
- +45 ;; contraindication.
- +46 ;;
- +47 ;;E. Diagnosis:
- +48 ;;
- +49 ;; 1. In reactivated cases, is this reactivation of the old disease
- +50 ;; or a separate and distinct new infection?
- +51 ;;
- +52 ;;ADDITIONAL NOTE TO THE EXAMINER:
- +53 ;;
- +54 ;;In all claims, if the disease is inactive and if the inactivity was confirmed
- +55 ;;at a non-VA facility, obtain the name and mailing address of the facility
- +56 ;;from the veteran so that the Regional Office may request the report.
- +57 ;;
- +58 ;;
- +59 ;;Signature: Date:
- +60 ;;END